Synergy Vision expands global presence to meet demand in the Asia-Pacific region

pharmafile | October 20, 2015 | News story | Medical Communications Asia-Pacific, Australia, Sydney, Synergy Vision, asia pacific, medical communcations 

UK-based Synergy Vision opens a new office in Sydney, Australia, to meet the demands of their clients across the Asia-Pacific region. With the rapidly expanding pharmaceutical sector in the Asia-Pacific region, the new office will provide clients in this region with local knowledge, combined with the worldwide skills and resources of their established offices. Synergy Vision is an award-winning medical communications agency that believes in developing and delivering medical communications programmes that make a difference to healthcare professionals and patients. The company was founded over eight years ago and is enjoying continued growth, with offices worldwide and a growing global team. Corinne Whitehead, Account Director, who has been with Synergy Vision for seven years, is heading up the Asia Pacific office. Prior to joining Synergy Vision, Corinne worked in a wide range of sectors for the pharmaceutical, banking and IT industries. Corinne’s wealth of experience in global pharmaceutical compliance and understanding of local regulations will be invaluable to clients in this region. The opening of the Asia-Pacific office is part of an ongoing expansion programme. Synergy Vision now has offices in London, Dublin and Sydney, and an alliance with BoomCom, based in Colorado, USA. This increasing worldwide presence will provide clients with seamless communications strategy and programme implementation across Europe, the Americas and the Asia-Pacific region. Ffyona Dawber, Managing Director, comments on the latest expansion, “The new office in Sydney enhances our commitment to provide clients with unparalleled global medical communications. It is another step towards delivering a truly global reach, enabling us to meet the local needs of our clients around the world.” For more information please contact: Corinne Whitehead Email: Tel: + 61(0) 406 600 955

Related Content


Australia pauses AstraZeneca vaccine for people under 60

Australia will now only recommend that people over 60 receive the AstraZeneca vaccine due to …

Australian study sees 70% HPV reduction in gay and bisexual men

A school-based human papillomavirus (HPV) vaccination study programme, led by Monash University and Alfred Health, …

Australian PM calls for domestic mRNA vaccine production

Australian Prime Minister, Scott Morrison, has invited proposals from pharmaceutical firms to establish domestic manufacturing …

Latest content